Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...

“Photon Design's next-generation, EPIPPROP simulator, will offer the flexibility to split waveguides, simulating this process ...

When technologies cross certain adoption thresholds, something changes in the market. This is what has happened to the IoT ...

CTO explains how the new standard supports real-time trading, stronger security, and data-heavy financial operations.

The latest announcement is out from Ovid Therapeutics ( (OVID) ).

Researchers have developed a fiber neural network system that performs intelligent processing of optical communication signals directly in the light domain. This approach integrates optical ...

LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered immune-tolerance-restoring therapies, announced today that the first patient ...

Even if fly-halves are considered to be the brainiest members of any team – a cliché that line-out callers might contest – ...